# Validation of Bulbicam for DR- and AMD-patients

> **NCT05441072** · — · COMPLETED · sponsor: **Meddoc** · enrollment: 64 (actual)

## Conditions studied

- Diabetic Retinopathy
- Age-Related Macular Degeneration

## Interventions

- **DEVICE:** BulbiCam

## Key facts

- **NCT ID:** NCT05441072
- **Lead sponsor:** Meddoc
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-19
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-06-15
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2024-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05441072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05441072, "Validation of Bulbicam for DR- and AMD-patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05441072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*